Gross chromosomal rearrangements (GCRs) have been identified as mutations that underlie different inherited genetic diseases, as mutations that drive the development of cancer and as loss of heterozygosity events that uncover recessive mutations in tumor suppressor genes. GCRs also result from the increased genome instability is seen in many cancers and may reflect a type of mutator phenotype. Inherited cancer susceptibility syndromes have been identified that are associated with increased spontaneous or DNA damage-induced genome instability, although whether the GCRs that arise drive the development of cancer is less clear. While genome instability is being intensely studied, our knowledge of the pathways and mechanisms that prevent genome instability remains limited. Understanding these mechanisms and pathways will impact on human health for several reasons: 1) Identifying the genes that suppress genome instability will provide new candidate tumor suppressor genes for investigation and candidate genes in which polymorphisms may interact with environmental agents;and 2) Many chemotherapeutic agents damage DNA and understanding how damage interacts with the pathways that suppress genome instability could lead to improvements in the efficacy of these agents as well as the development of new therapeutic approaches. In the proposed studies, Saccharomyces cerevisiae will be used as a model system to identify the genes and pathways that act to suppress GCRs. Key long term goals of these studies are to identify the types of metabolic errors, chromosomal features and mechanisms that contribute to genome instability and identify candidate genes in which defects might cause genome instability in cancer cells. The proposed work will build on insights obtained using previously developed quantitative systems for studying the formation of GCRs in S. cerevisiae. The following experimental approaches will be pursued: 1) New GCR assays and robust methods for mapping the structures of GCRs will be developed;2) High throughput genetic analysis of a bioinformatics- derived set of enriched candidate genes will be performed using different GCR assays to identify the genes and pathways that suppress specific kinds of GCRs;3) Genetic studies will be performed to determine the mechanisms that suppress GCRs mediated by duplicated sequences like segmental duplications;4) The mechanistic features of some of the pathways that suppress GCRs will be investigated, initially focusing on the study of Rpa, Esc2, chromatin remodeling factors and the suppression of homeologous recombination;5) Biochemical studies of homeologous recombination and break-induced replication will be performed to better understand how these pathways are regulated to prevent the formation of GCRs;and 6) Mouse and Human homologues of the S. cerevisiae genome instability genes will be identified to extend the study of genome instability to mouse and, ultimately, human systems. The results of these studies will be a comprehensive picture of the pathways and mechanisms that prevent GCRs.

Public Health Relevance

Increased genome instability is seen in many cancers and is thought to reflect a type of mutator phenotype that drives the development and progression of cancer. This project will identify the genes and pathways that prevent genome rearrangements from occurring. Identifying these genes and pathways will provide new candidate tumor suppressor genes for investigation and provide genetic tools for use in improving the efficacy of known chemotherapeutic agents as well as for use in the development of new therapeutic approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM026017-36
Application #
8240474
Study Section
Molecular Genetics B Study Section (MGB)
Program Officer
Janes, Daniel E
Project Start
1978-12-01
Project End
2014-03-31
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
36
Fiscal Year
2012
Total Cost
$443,236
Indirect Cost
$165,345
Name
Ludwig Institute for Cancer Research Ltd
Department
Type
DUNS #
627922248
City
La Jolla
State
CA
Country
United States
Zip Code
92093
de Souza, Jorge E S; Fonseca, André F; Valieris, Renan et al. (2014) S-score: a scoring system for the identification and prioritization of predicted cancer genes. PLoS One 9:e94147
Allen-Soltero, Stephanie; Martinez, Sandra L; Putnam, Christopher D et al. (2014) A saccharomyces cerevisiae RNase H2 interaction network functions to suppress genome instability. Mol Cell Biol 34:1521-34
Putnam, Christopher D; Pallis, Katielee; Hayes, Tikvah K et al. (2014) DNA repair pathway selection caused by defects in TEL1, SAE2, and de novo telomere addition generates specific chromosomal rearrangement signatures. PLoS Genet 10:e1004277
Jaehnig, Eric J; Kuo, Dwight; Hombauer, Hans et al. (2013) Checkpoint kinases regulate a global network of transcription factors in response to DNA damage. Cell Rep 4:174-88
Albuquerque, Claudio P; Wang, Guoliang; Lee, Nancy S et al. (2013) Distinct SUMO ligases cooperate with Esc2 and Slx5 to suppress duplication-mediated genome rearrangements. PLoS Genet 9:e1003670
Enserink, Jorrit M; Kolodner, Richard D (2012) What makes the engine hum: Rad6, a cell cycle supercharger. Cell Cycle 11:249-52
Chan, Jason E; Kolodner, Richard D (2011) A genetic and structural study of genome rearrangements mediated by high copy repeat Ty1 elements. PLoS Genet 7:e1002089
Zimmermann, Christine; Chymkowitch, Pierre; Eldholm, Vegard et al. (2011) A chemical-genetic screen to unravel the genetic network of CDC28/CDK1 links ubiquitin and Rad6-Bre1 to cell cycle progression. Proc Natl Acad Sci U S A 108:18748-53
Kolodner, Richard D; Cleveland, Don W; Putnam, Christopher D (2011) Cancer. Aneuploidy drives a mutator phenotype in cancer. Science 333:942-3
Wang, Yuxun; Zhang, Weijia; Edelmann, Lisa et al. (2010) Cis lethal genetic interactions attenuate and alter p53 tumorigenesis. Proc Natl Acad Sci U S A 107:5511-5

Showing the most recent 10 out of 72 publications